Showing results (201-210 of 270) with videos related to

Sort By:
Pageof 27
Journal of Hypertension. Supplement : Official Journal of the International Society of Hypertension|December 1, 1987
The interaction between noradrenaline and angiotensin II in man: evidence for a postsynaptic and against a presynaptic interactionP H Seidelin, W J Coutie, M S Pai, et al.
European Heart Journal|December 24, 1997
Right coronary artery stenosis is associated with impaired cardiac endocrine function during exerciseN C Davidson, S D Pringle, T H Pringle, et al.
BMJ (Clinical Research Ed.)|April 6, 1996
Sensitivity and specificity of QTc dispersion for identification of risk of cardiac death in patients with peripheral vascular diseaseD Darbar, J Luck, N Davidson, et al.
Clinical Pharmacology and Therapeutics|December 1, 1993
Dose-ranging effects of candoxatril on elimination of exogenous atrial natriuretic peptide in chronic heart failureJ G Motwani, C C Lang, M J Allen, et al.
The Journal of Clinical Endocrinology and Metabolism|February 1, 1983
Calcium antagonists and hormone release: effect of nifedipine on luteinizing hormone-releasing hormone and thyrotropin-releasing hormone-induced pituitary hormone releaseA D Struthers, J A Millar, G H Beastall, et al.
Clinical Science (London, England : 1979)|May 1, 1986
Atrial natriuretic peptide inhibits the aldosterone response to angiotensin II in manJ V Anderson, A D Struthers, N N Payne, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|February 19, 2008
Vitamin D improves endothelial function in patients with Type 2 diabetes mellitus and low vitamin D levelsJ A Sugden, J I Davies, M D Witham, et al.
BMJ (Clinical Research Ed.)|March 29, 1997
Cross sectional study of contribution of clinical assessment and simple cardiac investigations to diagnosis of left ventricular systolic dysfunction in patients admitted with acute dyspnoeaN D Gillespie, G McNeill, T Pringle, et al.
British Journal of Clinical Pharmacology|March 1, 1997
The effect of the neutral endopeptidase inhibitor drug, candoxatril, on circulating levels of two of the most potent vasoactive peptidesG McDowell, W Coutie, C Shaw, et al.
Hypertension (Dallas, Tex. : 1979)|February 19, 1999
Irbesartan reduces QT dispersion in hypertensive individualsP O Lim, M Nys, A A Naas, et al.
Pageof 27